<DOC>
	<DOCNO>NCT01267357</DOCNO>
	<brief_summary>P16 tumor suppressor protein implicate serous papillary endometrial carcinoma . Evidence previous trial indicate may use diagnostic biomarker distinguish disease endometrioid endometrial cancer . Additional evidence point prognostic value . The current study evaluate p16 diagnostic tool serous papillary endometrial cancer prognostic biomarker . follow anonymization , histology block microtomed stained P16 P53 protein . Blocks endometrioid endometrial cancer use control group .</brief_summary>
	<brief_title>P16 Staining Prognostic Biomarker Serous Papillary Endometrial Cancer</brief_title>
	<detailed_description />
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<criteria>diagnosis endometrial cancer histology block exist hospital 's library</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Serous Papillary Endometrial Cancer</keyword>
	<keyword>Endometrioid endometrial cancer</keyword>
	<keyword>biomarkers</keyword>
	<keyword>P16</keyword>
	<keyword>P53</keyword>
	<keyword>Prognosis</keyword>
</DOC>